The DYRK1A enzyme is a pivotal contributor to frequent and severe episodes of otitis media in Down syndrome, positioning it as a promising target for therapeutic interventions.
Unveiling the circuit organization and functional roles of endopiriform neurons projecting to the ventral CA1.